Skip to main content
. 2014 Mar 28;35(23):1541–1550. doi: 10.1093/eurheartj/ehu075

Figure 3.

Figure 3

Cumulative Kaplan–Meier estimates of the incidence of the primary composite outcome—cardiovascular death/myocardial infarction/stroke, by sex and treatment (ticagrelor vs. clopidogrel). Estimated event rate at 12 months, ticagrelor vs. clopidogrel, interaction P = 0.88. CV death, death from cardiovascular causes; MI, myocardial infarction.